Sue Friedman Provides an Overview of the ABOUT Network

July 7, 2015

Article

Sue Friedman, discusses the ABOUT Network, which is the first-ever patient-powered research registry created and governed by and for people affected by hereditary breast and ovarian cancers.

Sue Friedman, Executive Director, FORCE (Facing Our Risk of Cancer Empowered), discusses the ABOUT Network, which is the first-ever patient-powered research registry created and governed by and for people affected by hereditary breast and ovarian cancers.

Related Content

Neoadjuvant Niraparib/Dostarlimab Combo May Yield pCRs in BRCS+, ER+/HER2- Breast Cancer

Ariana Pelosci

December 19th 2024

Article

Additional exploration may help fully realize the impact of combining immunologic approaches with PARP inhibition, says one expert.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer

October 2nd 2023

Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

Addition of Perioperative Atezolizumab Does Not Improve EFS in TNBC

Jason Broderick

December 16th 2024

Article

Perioperative atezolizumab did not improve outcomes in patients with triple-negative breast cancer.

Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

Lindsay Fischer

June 15th 2023

Podcast

Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.

Immediate Surgery Lowers Local Recurrence in Older Breast Cancer Population

Russ Conroy

December 14th 2024

Article

“This benefit in local recurrence translates into a later difference in distant recurrence and breast cancer [mortality], but it’s only apparent with long follow-up,” according to the study author.